10/28/2026
Pharma giants invest billions in psychedelics despite hurdles
Psychedelics like MDMA and psilocybin gain traction amid regulatory challenges.
Topic archive
3 stories
10/28/2026
Psychedelics like MDMA and psilocybin gain traction amid regulatory challenges.
9/15/2026
Exploring the promise and risks of psychedelic treatments in mental health.
8/18/2026
Governor's order initiates ibogaine, MDMA, and psilocybin study